Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS

Status: Recruiting
Location: See all (4) locations...
Study Type: Observational
SUMMARY

CAPTURE ALS is a long-term data and biorepository platform that will facilitate future ALS research. CAPTURE ALS will provide the standardized systems and tools necessary to collect, store, and analyze vast amounts of multimodal information about ALS. These multimodal datasets and biosamples will be made available for use by researchers or industry across Canada and around the world in accordance with the CAPTURE ALS Data Sharing Policy to advance research on ALS.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Has ALS, classified as definite, probable, laboratory-supported probable, or possible ALS according to the revised El Escorial criteria or a related neurodegenerative disorder including ALS-FTD, PLS, PMA or asymptomatic individuals with a known ALS mutation (as previously confirmed during regular clinical care)

• Be of the age of majority in their province of residence/treatment

• Have the cognitive capacity to provide informed consent

• Have proficiency in English or French in order to understand study instructions and respond to questionnaires

• Be between the ages of 40-80 unless age matched to a patient (+/-3 years) who is already enrolled

• Be the age of majority in their province of residence/treatment

• Have the cognitive capacity to provide informed consent

• Have proficiency in English of French to understand study instructions and respond to questionnaires

Locations
Other Locations
Canada
University of Alberta
RECRUITING
Edmonton
McGill University / Montreal Neurological Institute and Hospital
RECRUITING
Montreal
CHU de Quebec -Universite de Laval
RECRUITING
Québec
University of Toronto / Sunnybrook Health Sciences Centre
RECRUITING
Toronto
Contact Information
Primary
Claire Magnussen, PhD
info@captureals.ca
514-398-6188
Backup
Sara Moradipoor
moradipo@ualberta.ca
780-248-1805
Time Frame
Start Date: 2021-09-12
Estimated Completion Date: 2025-12
Participants
Target number of participants: 150
Sponsors
Collaborators: Simon Fraser University, McGill University, University of Toronto, Laval University
Leads: University of Alberta

This content was sourced from clinicaltrials.gov